Literature DB >> 26126171

Cell cycle status dictates effectiveness of rapamycin.

Wenjian Gan1, Pengda Liu, Wenyi Wei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26126171      PMCID： PMC5242318          DOI： 10.1080/15384101.2015.1060778

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

Review 1.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

2.  Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.

Authors:  Mahesh Saqcena; Deven Patel; Deepak Menon; Suman Mukhopadhyay; David A Foster
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

Review 3.  mTOR kinase inhibitors as potential cancer therapeutic drugs.

Authors:  Shi-Yong Sun
Journal:  Cancer Lett       Date:  2013-06-20       Impact factor: 8.679

Review 4.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

5.  Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways.

Authors:  Amrita Chatterjee; Suman Mukhopadhyay; Kaity Tung; Deven Patel; David A Foster
Journal:  Cancer Lett       Date:  2015-02-03       Impact factor: 8.679

6.  Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools.

Authors:  Ahmet Koç; Linda J Wheeler; Christopher K Mathews; Gary F Merrill
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

Review 7.  mTOR-dependent cell survival mechanisms.

Authors:  Chien-Min Hung; Luisa Garcia-Haro; Cynthia A Sparks; David A Guertin
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005
  7 in total
  3 in total

1.  A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells.

Authors:  Deven Patel; Darin Salloum; Mahesh Saqcena; Amrita Chatterjee; Victoria Mroz; Michael Ohh; David A Foster
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

2.  Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin.

Authors:  Sohag Chakraborty; Matthew B Utter; Maria A Frias; David A Foster
Journal:  Cancer Lett       Date:  2021-09-23       Impact factor: 8.679

3.  Local application of rapamycin reduces epidural fibrosis after laminectomy via inhibiting fibroblast proliferation and prompting apoptosis.

Authors:  Yu Sun; Shuai Zhao; Xiaolei Li; Lianqi Yan; Jingcheng Wang; Daxin Wang; Hui Chen; Jihang Dai; Jun He
Journal:  J Orthop Surg Res       Date:  2016-05-06       Impact factor: 2.359
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.